Skip to main content

Invivo Therapeutics Holdings Corp.

NVIVDelisted Mar 21, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001292519

Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Invivo Therapeutics Holdings Corp. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
20
+3 vs. Q4 2022
Shares held
116.4K
−189.5K (−61.9%) vs. Q4 2022
Total value
$123.7K
−$595.0K (−82.8%) vs. Q4 2022
New holders
7
2 more added
Sold out
4
3 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NVIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 20 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 1 institutionQ2 2022: 13 institutionsQ3 2022: 16 institutionsQ4 2022: 17 institutionsQ1 2023: 20 institutionsQ2 2023: 15 institutionsQ3 2023: 15 institutionsQ4 2023: 14 institutionsQ1 2024: 4 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $123.7K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $1.00KQ2 2022: $257.0KQ3 2022: $703.0KQ4 2022: $718.7KQ1 2023: $123.7KQ2 2023: $131.0KQ3 2023: $118.5KQ4 2023: $68.1KQ1 2024: $5.22KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NVIV and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20244$5.22K
Q4 202314$68.1K
Q3 202315$118.5K
Q2 202315$131.0K
Q1 202320$123.7K
Q4 202217$718.7K
Q3 202216$703.0K
Q2 202213$257.0K
Q1 20221$1.00K
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Invivo Therapeutics Holdings Corp.; share changes are against Q4 2022.

Institutions holding NVIV in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock Inc.34,714$36.8K0.00%00.0%Unchanged
Vanguard Group Inc26,246$27.8K0.00%+9,300+54.9%Added
Millennium Management LLC13,280$14.0K0.00%+13,280New
Two Sigma Securities, LLC12,870$13.6K0.00%+12,870New
Renaissance Technologies LLC11,025$12.0K0.00%+900+8.9%Added
Geode Capital Management, LLC11,169$11.8K0.00%00.0%Unchanged
UBS Group AG3,740$3.96K0.00%−527−12.4%Reduced
Tower Research Capital LLC (TRC)1,784$2.00K0.00%−3,363−65.3%Reduced
Morgan Stanley1,469$1.56K0.00%−31−2.1%Reduced
National Bank of Canada20$210.00%+20New
Wells Fargo & Company13$140.00%00.0%Unchanged
TD Waterhouse Canada Inc.6$80.00%+6New
Advisor Group Holdings, Inc.7$70.00%00.0%Unchanged
Colonial Trust Advisors2$20.00%00.0%Unchanged
Farther Finance Advisors, LLC2$20.00%00.0%Unchanged
Allworth Financial LP1$20.00%+1New
Milestone Investment Advisors LLC1$20.00%+1New
Sugarloaf Wealth Management, LLC1$10.00%00.0%Unchanged
WealthPLAN Partners, LLC1$10.00%+1New
Royal Bank of Canada69$00.00%00.0%Unchanged
Armistice Capital, LLC0$00.00%−222,000−100.0%Sold out
Coastal Capital Group, Inc.0$00.00%−1−100.0%Sold out
JPMorgan Chase & Co0$00.00%−1−100.0%Sold out
IFP Advisors, Inc0$00.00%−1−100.0%Sold out